<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Variations in TRAbs in Graves' hyperthyroidism after radioiodine, surgery, or medical therapy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Variations in TRAbs in Graves' hyperthyroidism after radioiodine, surgery, or medical therapy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Variations in TRAbs in Graves' hyperthyroidism after radioiodine, surgery, or medical therapy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Variations in TRAbs in serum after randomly assigning patients with Graves' hyperthyroidism to radioiodine (n = 36; radioiodine was only given to patients ≥35 years of age), surgery (n = 47), or medical therapy (n = 48). In all groups, patients were kept euthyroid by the addition of levothyroxine therapy as appropriate. Medical therapy was given for 18 months. The values for the patients who needed a treatment other than the randomized are omitted beyond the time the change occurred. Values are mean±SEM. The upper normal reference for the TRAb assay was 10%, as indicated by the straight dashed line. Values before therapy were not different between groups. After therapy, all values were significantly higher for the radioiodine group when compared with values for the medical or surgical therapy groups (p&lt;0.01).</div><div class="graphic_footnotes">TSH: thyroid-stimulating hormone; TRAb: thyrotropin receptor antibodies; 125-I: iodine-125; SEM: standard error of mean.</div><div class="graphic_reference">Reproduced with permission from: Laurberg P, Wallin G, Tallstedt L, et al. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: A 5-year prospective randomized study. Eur J Endocrinol 2008; 158:69. Copyright © 2008 BioScientifica Ltd.</div><div id="graphicVersion">Graphic 115288 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
